Biotech Stock Dermata Therapeutics, Inc. (Nasdaq: DRMA) Makes NASDAQ Top Gainer List on Positive Phase 3 Results
C2000-2021 InvestorIdeas.com tm
Read more: https://www.investorideas.com/news/2025/biotech/03281Dermata-Therapeutics-DRMA.asp
Text source: Investorideas.com newswire, breaking stock market